Search

Gerard C Karsenty

from Bayville, NJ
Age ~83
Get Report
Also known as:
Gerard P Karsenty, Gerard L Karsenty, Gerald Karsenty, Gerard C Apsley, Gerard Y
Phone and address:
112 Iger Way, Berkeley Township, NJ 08721
(908) 507-3288
Related to:
Robert Hanley, 66Dena B Krischer, 44Janice B Apsley, 60Denise A Braun, 65William K Apsley, 36Jill A Apsley, 58Robert W Apsley, 63Richard W Apsley, 60Diane A Hoffman, 64Kenneth W Apsley, 66Barbara A Karsenty, 89Heather L Apsley, 37Katie N Ricks, 39
Connected to:
David G Karsenti, 59Michel E Karsenti, 77Arlene E Karsh, 75Brian M Karsh, 48Bonnie L Karshbaum, 56Ahmed Karshe, 36Ashley D Karshen, 36Philipp G Karshens, 72Mikhail I Karshigiyev, 43Rose Karshis, 32

Gerard Karsenty Phones & Addresses

  • 112 Iger Way, Bayville, NJ 08721 (908) 507-3288
  • 16 Orlando Blvd, Toms River, NJ 08757 (732) 736-7410 (908) 526-0197
  • Branchburg, NJ
  • Clinton, NJ
  • Scotch Plains, NJ
  • South Amboy, NJ
  • Whitehouse, NJ

Public records

Vehicle Records

Gerard Karsenty

View page
Address:
16 Orlando Blvd, Toms River, NJ 08757
Phone:
(908) 526-5929
VIN:
5S3ET13M372804867
Make:
SAAB
Model:
9-7X
Year:
2007

Resumes

Resumes

Gerard Karsenty Photo 1

Ecole Dordor

View page
Location:
Toms River, NJ
Industry:
Recreational Facilities And Services
Work:
Toms River New Jersey
Ecole Dordor
Skills:
Customer Service
Gerard Karsenty Photo 2

Watchmaker

View page
Location:
Bayville, NJ
Work:
Gerardsjewelers
Watchmaker
Gerard Karsenty Photo 3

Gerard Karsenty

View page
Gerard Karsenty Photo 4

Gerard Karsenty

View page
Location:
United States

Business Records

Name / Title
Company / Classification
Phones & Addresses
Gerard C. Karsenty
Gerard's Watch & Jewelry Sales
Jewelry Stores
864-B Route 37 W, Toms River, NJ 08755
(908) 507-3288
Gerard Karsenty
Owner
Gerard's Watch & Jewelry
Ret Jewelry
4 Leigh St, Clinton, NJ 08809
(908) 735-5071

Publications

Amazon

Chapter 017, Significance Of Organ Crosstalk In Insulin Resistance And Type 2 Diabetes

Chapter 017, Significance of Organ Crosstalk in Insulin Resistance and Type 2 Diabetes

View page

NOTE: This is a single chapter excerpted from the book Translational Endocrinology of Bone, made available for individual purchase. Additional chapters, as well as the entire book, may be purchased separately. The use of model organisms together with the power of genetics has profoundly affected our...
Author

Gerard Karsenty

Binding

Kindle Edition

Pages

57

Publisher

Academic Press

ISBN #

10

Chapter 016, Clinical Implications Of Serotonin Regulation Of Bone Mass

Chapter 016, Clinical Implications of Serotonin Regulation of Bone Mass

View page

NOTE: This is a single chapter excerpted from the book Translational Endocrinology of Bone, made available for individual purchase. Additional chapters, as well as the entire book, may be purchased separately. The use of model organisms together with the power of genetics has profoundly affected our...
Author

Gerard Karsenty

Binding

Kindle Edition

Pages

30

Publisher

Academic Press

ISBN #

9

Chapter 015, Osteocalcin, Undercarboxylated Osteocalcin, And Glycemic Control In Human Subjects

Chapter 015, Osteocalcin, Undercarboxylated Osteocalcin, and Glycemic Control in Human Subjects

View page

NOTE: This is a single chapter excerpted from the book Translational Endocrinology of Bone, made available for individual purchase. Additional chapters, as well as the entire book, may be purchased separately. The use of model organisms together with the power of genetics has profoundly affected our...
Author

Gerard Karsenty

Binding

Kindle Edition

Pages

22

Publisher

Academic Press

ISBN #

8

Chapter 010, Regulation Of Bone Resorption By Pparγ

Chapter 010, Regulation of Bone Resorption by PPARγ

View page

NOTE: This is a single chapter excerpted from the book Translational Endocrinology of Bone, made available for individual purchase. Additional chapters, as well as the entire book, may be purchased separately. The use of model organisms together with the power of genetics has profoundly affected our...
Author

Gerard Karsenty

Binding

Kindle Edition

Pages

56

Publisher

Academic Press

ISBN #

7

Chapter 007, Gut-Derived Serotonin And Bone Formation

Chapter 007, Gut-derived Serotonin and Bone Formation

View page

NOTE: This is a single chapter excerpted from the book Translational Endocrinology of Bone, made available for individual purchase. Additional chapters, as well as the entire book, may be purchased separately. The use of model organisms together with the power of genetics has profoundly affected our...
Author

Gerard Karsenty

Binding

Kindle Edition

Pages

30

Publisher

Academic Press

ISBN #

6

Chapter 006, Gastrointestinal Tract And The Control Of Bone Mass

Chapter 006, Gastrointestinal Tract and the Control of Bone Mass

View page

NOTE: This is a single chapter excerpted from the book Translational Endocrinology of Bone, made available for individual purchase. Additional chapters, as well as the entire book, may be purchased separately. The use of model organisms together with the power of genetics has profoundly affected our...
Author

Gerard Karsenty

Binding

Kindle Edition

Pages

27

Publisher

Academic Press

ISBN #

5

Chapter 001, Introduction: The Rational Of The Work Or The Overarching Hypothesis

Chapter 001, Introduction: The Rational of the Work or the Overarching Hypothesis

View page

NOTE: This is a single chapter excerpted from the book Translational Endocrinology of Bone, made available for individual purchase. Additional chapters, as well as the entire book, may be purchased separately. The use of model organisms together with the power of genetics has profoundly affected our...
Author

Gerard Karsenty

Binding

Kindle Edition

Pages

11

Publisher

Academic Press

ISBN #

4

Chapter 002, Basic Principles Of Bone Cell Biology

Chapter 002, Basic Principles of Bone Cell Biology

View page

NOTE: This is a single chapter excerpted from the book Translational Endocrinology of Bone, made available for individual purchase. Additional chapters, as well as the entire book, may be purchased separately. The use of model organisms together with the power of genetics has profoundly affected our...
Author

Gerard Karsenty

Binding

Kindle Edition

Pages

60

Publisher

Academic Press

ISBN #

3

Us Patents

Compositions And Methods For Modulating Bone Mass

View page
US Patent:
20090202572, Aug 13, 2009
Filed:
May 13, 2006
Appl. No.:
11/913168
Inventors:
Gerard Karsenty - New York NY, US
Bruce Devens - Oakland CA, US
International Classification:
A61K 39/395
C07C 215/60
C07D 285/10
C07C 217/72
C07K 7/06
C07K 16/00
A61K 31/138
A61K 31/137
A61K 31/433
A61K 38/22
A61P 19/10
US Classification:
4241781, 564360, 548134, 564348, 530329, 5303917, 514651, 514653, 514362, 514 12
Abstract:
The instant invention relates to compositions and methods for treating or preventing bone diseases. In certain aspects, the invention provides compositions comprising a β-adrenergic antagonist or agonist associated to a bone-targeted molecule, as well as methods of modulating bone mass and/or growth in a mammal by administering a composition of the present invention. In other aspects, the invention provides methods of modulating bone mass and/or growth in a mammal by administering a composition comprising a β2-selective antagonist or agonist.

Methods For Identifying Or Assaying For Agents That Increase Beta-Cell Proliferation, Insulin Secretion, Insulin Sensitivity, Glucose Tolerance And Decrease Fat Mass

View page
US Patent:
20100048409, Feb 25, 2010
Filed:
Sep 13, 2007
Appl. No.:
12/441060
Inventors:
Gerard Karsenty - New York NY, US
Patricia F. Ducy - New York NY, US
International Classification:
C40B 30/00
C12Q 1/02
US Classification:
506 7, 435 29
Abstract:
The present invention is directed to cell-based and non-cell based methods of drug screening to identify agents, or assay agents, that reduce OST-PTP or gamma-carboxylase activity or expression, or increase the level of undercarboxylated osteocalcin or adiponectin activity or expression. Such agents find use in treating or preventing a disorder related to the OST-PTP signaling pathway. Such disorders include, metabolic syndrome, glucose intolerance, type 1 or type 2 diabetes, atherosclerosis, or obesity. Such agents may be used to treat disorders characterized by decreased insulin production, deceased insulin sensitivity, and decreased glucose tolerance or increased fat mass.

Undercarboxylated/Uncarboxylated Osteocalcin Increases Beta-Cell Proliferation, Insulin Secretion, Insulin Sensitivity, Glucose Tolerance And Decreases Fat Mass

View page
US Patent:
20100190697, Jul 29, 2010
Filed:
Sep 13, 2007
Appl. No.:
12/441045
Inventors:
Gerard Karsenty - New York NY, US
Patricia F. Ducy - New York NY, US
Assignee:
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY IF - New York NY
International Classification:
A61K 38/16
A61P 3/10
A61P 3/04
A61P 3/14
A61P 3/00
C07K 14/435
G01N 33/68
US Classification:
514 12, 530350, 436 86
Abstract:
The present invention relates to methods and compositions for treating and diagnosing disorders related to energy metabolism and the OST-PTP signaling pathway involving gamma-carboxylase, osteocalcin and adiponectin. Such disorders include, but are not limited to, metabolic syndrome, glucose intolerance, diabetes types 1 and 2, atherosclerosis and obesity.

Methods For Treating Or Preventing Diseases Associated With Low Bone Mass

View page
US Patent:
20100260772, Oct 14, 2010
Filed:
Sep 26, 2008
Appl. No.:
12/680391
Inventors:
Gerard Karsenty - New York NY, US
Assignee:
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK - New York NY
International Classification:
A61K 39/395
A61K 31/12
A61K 31/137
A61K 31/495
A61K 31/496
A61K 31/497
A61P 19/00
A61P 19/10
US Classification:
4241581, 4241721, 514689, 514646, 51425503, 51425304, 51425306, 51425211, 51425405
Abstract:
Methods of treating or preventing diseases associated with low bone mass in a mammal in need of such treatment or prevention comprising administering to the mammal a therapeutically effective amount of an agent that increases tryptophan hydroxylase 2 activity or of an agonist of the brain serotonin HT2C receptor. Diseases associated with low bone mass include osteoporosis, osteopenia, Paget's disease, osteomalacia, and renal osteodystrophy.

Methods Of Preventing And Treating Low Bone Mass Diseases

View page
US Patent:
20110281899, Nov 17, 2011
Filed:
Nov 13, 2009
Appl. No.:
13/128987
Inventors:
Gerard Karsenty - New York NY, US
Patricia F. Ducy - New York NY, US
Vijay Kumar Yadav - Cambridge, GB
Donald Landry - New York NY, US
Assignee:
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK - New York NY
International Classification:
A61K 31/513
C07D 409/12
A61P 19/08
C07D 403/12
C07D 413/12
C07D 417/12
C07D 401/12
C07D 405/12
US Classification:
514272, 544321, 544319, 544296, 514269
Abstract:
The present invention provides methods and therapeutic agents for lowering or increasing serum serotonin levels in a patient in order to increase or decrease bone mass, respectively. In preferred embodiments, the patient is known to have, or to be at risk for, a low bone mass disease such as osteoporosis and the agents are TPH1 inhibitors or serotonin receptor antagonists.

Methods Of Suppressing Appetite By The Administration Of Antagonists Of The Serotonin Htr1A Or Htr2B Receptors Or Inhibitors Of Tph2

View page
US Patent:
20120115778, May 10, 2012
Filed:
Jul 15, 2010
Appl. No.:
13/383050
Inventors:
Gerard Karsenty - New York NY, US
Vijay Yadav - Hinxton, GB
Franck Oury - New York NY, US
Assignee:
The Trustees of Columbia University in the City of New York - New York City NY
International Classification:
A61K 31/496
A61K 31/353
A61K 31/438
A61K 31/495
A61K 31/4045
A61P 19/00
A61K 31/404
A61K 31/473
A61K 38/22
A61P 3/00
A61P 3/04
A61K 31/4365
A61K 31/382
US Classification:
514 53, 514291, 514456, 51425301, 51425312, 514278, 51425503, 51425404, 51425311, 514419, 51425411, 514432, 51425406, 51425213, 514415, 51425307, 51425409, 514297
Abstract:
Methods for treating eating disorders associated with excessive weight gain, suppressing appetite, reducing body weight, or treating obesity in an animal by administering one or more antagonists of the serotonin Htr1a or Htr2b receptor, or a Tph2 inhibitor are provided, or combinations thereof.

Osteocalcin As A Treatment For Male Reproductive Disorders

View page
US Patent:
20130028902, Jan 31, 2013
Filed:
Jan 19, 2011
Appl. No.:
13/574196
Inventors:
Gerard Karsenty - New York NY, US
Patricia F. Ducy - New York NY, US
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
A61K 38/22
A61P 15/10
G01N 33/566
A61K 39/395
A61K 31/713
A61P 15/16
A61P 15/08
A61K 31/366
US Classification:
4241391, 514 98, 514456, 514 44 A, 435 792
Abstract:
Methods and compositions for treating, preventing, or diagnosing disorders related to reproduction in male mammals, preferably humans, are provided. The methods generally involve modulation of the OST-PTP signaling pathway or the PTP-IB signaling pathway involving gamma-carboxylase and osteocalcin. Disorders amenable to treatment by the methods include, but are not limited to, male infertility, low sperm count, impaired sperm motility, impaired sperm viability, low testosterone levels, reduced libido, erectile dysfunction, underdevelopment of testes, and excess apoptosis in testes.

Methods Of Preventing And Treating Hyperlipidemia Or Atherosclerosis

View page
US Patent:
20130338176, Dec 19, 2013
Filed:
Oct 28, 2011
Appl. No.:
13/882394
Inventors:
Gerard Karsenty - New York NY, US
Grzegorz Sumara - Wuerzburg, DE
Assignee:
The Trustees of Columbia University in the City of New York - New York NY
International Classification:
A61K 31/505
A61K 45/06
US Classification:
514272
Abstract:
The present invention provides methods and therapeutic agents for lowering serum or plasma serotonin levels in a patient in order to prevent or treat hyperlipidemia or atherosclerosis. In preferred embodiments, the patient is known to have, or to be at risk for, hyperlipidemia or atherosclerosis and the agents are TPH1 inhibitors.
Control profile
Gerard C Karsenty from Bayville, NJ, age ~83 Get Report